Foreword_Abrahamsson.qxp 13/10/08 11:16 am Page 10
Foreword
Per-Anders Abrahamsson
Secretary General, European Association of Urology (EAU)
Per-Anders Abrahamsson is Secretary General of the European Association of Urology (EAU). He is also a Professor of Urology at the
University of Lund, Chair of the Department of Urology at Malmö University Hospital and an Adjunct Professor in the Department of Urology
at the University of Rochester Medical Center. Previously, he was Chairman of the Department of Urology at Lund University Hospital.
Professor Abrahamsson is the author of 275 scientific publications, including book chapters and books, and is a member of the Editorial
Boards of several scientific journals. He has been the main organiser of several international conferences, is a frequently invited speaker at
scientific meetings and has received a number of national and international awards. Professor Abrahamsson received his MD and PhD from
Lund University.
W
elcome to this edition of European Urological Review. This informative and varied publication features a range
of scientific articles that discuss and review key issues relevant to urologists in Europe and, indeed, worldwide.
This edition reviews the field of genito-urinary disease, covering 13 urological specialities from prostate cancer to
paediatric urology, emphasising the wide spectrum of both medical and surgical topics that are encompassed by the
speciality of urology.
The European Association of Urology (EAU) has developed an extensive and comprehensive programme of educational
and scientific activities relating to all of these important disease areas. The EAU annual meeting in Stockholm in March
2009 will be the main European and international forum where the latest advances in the field of urology will be
reviewed in detail. The 3rd European Multidisciplinary Meeting on Urological Cancers (EMUC) will be held in Barcelona
in November 2009 in collaboration with our colleagues in medical oncology and radiation therapy.
This issue opens with an overview of minimally invasive treatment for benign prostatic hyperplasia (BPH). Next, three
chapters focus on prostate cancer: an introductory chapter introduces HistoScanning™ and its role in prostate cancer
diagnosis, staging, treatment and monitoring; a second chapter provides an update on high-intensity focused ultrasound
(HIFU) as a local treatment for prostate cancer; and a separate chapter on prostatectomy reviews both the laparoscopic
and the robot-assisted laparoscopic approach.
Whether photodynamic diagnosis (PDD) and transurethral resection (TUR) can play a role in the detection and treatment
of bladder cancer is investigated in a second oncological chapter. Further articles deal with second-line treatment for
superficial bladder cancer and possible treatment of neuroendocrine carcinoma of the bladder.
Both overview articles and reviews of medical agents are tackled in the chapter on overactive bladder. Fesotoderine is
introduced as a new treatment option and transdermal oxybutynin is shown to be safe and effective. Transdermal
oxybutynin also plays a crucial role in the treatment of urinary incontinence. Looking at the important area of new medical
technology, there is a report on minimally invasive one-incision slings for the treatment of female stress urinary incontinence.
A comprehensive feature containing three articles on stone management follows this, covering intracorporeal lithotripsy,
ureteral calculi and optimised shock-wave lithotripsy. There is expert discussion on andrological topics as varied as erectile
dysfunction, premature ejaculation and male infertility. One of the articles explains the genetic basis of severe male factor
infertility and discusses what urologists need to know.
European Urological Review would like to thank everyone involved for successfully providing interesting and informative
expert discussion. We would like to say a big thank you to the individual authors for their time and effort. We trust that
you will find this edition an informative and enjoyable read. ■
10 © TOUCH BRIEFINGS 2008
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131